BCL2L10 is a predictive factor for resistance to Azacitidine in MDS and AML patients

Published 2015 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
BCL2L10 is a predictive factor for resistance to Azacitidine in MDS and AML patients
Authors
Keywords
-
Journal
Oncotarget
Volume 3, Issue 4, Pages -
Publisher
Impact Journals, LLC
Online
2015-09-17
DOI
10.18632/oncotarget.481

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.